<DOC>
	<DOCNO>NCT00330226</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety long-term psychopharmacotherapy schizophrenia bipolar disorder term psychopathology side effect .</brief_summary>
	<brief_title>Efficacy Safety Psychopharmacotherapy Patients With Schizophrenia Bipolar Disorders</brief_title>
	<detailed_description>Schizophrenia bipolar disorder renowned chronic deteriorate course . Although atypical antipsychotic mood stabilizer widely use treatment choice illness base acute efficacy safety , long-term efficacy safety agent still open debate . Prospective follow-up study naturalistic condition may useful way elucidate con pro long-term psychopharmacotherapy.In study , efficacy various side effect drug measure , possibility neurophysiological marker test serial measurement electroencephalographic change .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Male female patient , 1865 year age . Patients must diagnosis schizophrenia bipolar disorder accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) . Patients receive antipsychotic mood stabilizer within past 4 week prior study entry . Each patient must provide write informed consent full explanation study protocol , authorized legal guardian must understand nature study must also give assent study participation . History take antipsychotic mood stabilizer within past 4 week . History DSMIV substance dependence . Mental retardation ( IQ &lt; 70 ) patient able understand inform consent . Definite suspect organic mental disorder . Female patient able maintain contraception study Laboratory abnormalities clinical significance History epilepsy electroconvulsive therapy within past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>atypical antipsychotic</keyword>
	<keyword>mood stabilizer</keyword>
	<keyword>biological marker</keyword>
</DOC>